Evaluation of a new adrenomedullary imaging agent: 131I-meta-iodobenzylguanidine (131I-MIBG) . I: Experimental studies on animals
Troncone, L.; Rufini, V.; Campioni, P.; Valle, G.; Giordano, C.; Ala, G.; Deleide, G.; Orlando, P.
Rays 10(2): 117-124
1985
ISSN/ISBN: 0390-7740 PMID: 3843644 Document Number: 267280
Document emailed within 1 workday
Related Documents
Samnick, S.; Kirsch, C.M. 1999: A simple and rapid routine preparation of no-carrier added meta-I-123- and I-131-iodobenzylguanidine (I-123-MIBG and I-131-MIBG) for clinical nuclear medicine applications Nuklearmedizin. Nuclear Medicine 38(7): 292-296Lumbroso, J.D.; Guermazi, F.; Hartmann, O.; Coornaert, S.; Rabarison, Y.; Leclère, J.G.; Couanet, D.; Bayle, C.; Caillaud, J.M.; Lemerle, J. 1988: Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans Progress in Clinical and Biological Research 271: 689-705
Jindahra, P.; Vejjajiva, A.; Witoonpanich, R.; Sirisriro, R.; Sritara, C.; Pulkes, T. 2004: Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report) Journal of the Medical Association of Thailand 87(10): 1176-1181
Tsuchimochi, S.; Nakajo, M.; Nakabeppu, Y.; Tani, A. 1997: Metastatic pulmonary pheochromocytomas: positive I-123 MIBG SPECT with negative I-131 MIBG and equivocal I-123 MIBG planar imaging Clinical Nuclear Medicine 22(10): 687-690
Sisson, J.C.; Wieland, D.M. 1986: Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies American Journal of Physiologic Imaging 1(2): 96-103
Kazuta, T.; Hayashi, M.; Yoshita, M.; Hirai, S. 1998: Iodine-123-labeled meta-iodobenzylguanidine myocardial scintigraphy evaluation of Machado-Joseph disease Rinsho Shinkeigaku 38(2): 97-101
Liu, B.; Zhuang, H.; Servaes, S. 2013: Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 21-28
Villadsen, H.D.; Abrahamsen, J. 1997: Meta-iodobenzylguanidine scintigraphy of the heart Ugeskrift for Laeger 159(45): 6671-6675
Caballero, O.; Ferris, J.; Escobedo, J.M.; Pérez, A. 1989: Gammagraphy with 123I-meta-iodobenzylguanidine in the diagnosis of pheochromocytoma Medicina Clinica 92(14): 526-529
Fernández-Fresnedo, G.; Herráez, I.; Ruiz San Millán, J.C.; Sanz de Castro, S. 2000: False-negative with 123I-meta-iodobenzylguanidine in patients with pheochromocytoma Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 20(5): 464
Baulieu, J.L.; Guilloteau, D.; Fetissof, F.; Caron, J.; Lecomte, P.; Guilmot, J.L.; Lipinski, F.; Baulieu, F.; Itti, R.; Pourcelot, L. 1984: Sympathetic paraganglioma. Scintigraphic detection using a new labeled molecule, meta-iodobenzylguanidine Presse Medicale 13(27): 1679-1682
Troncone, L.; Rufini, V.; Maini, C.L.; Valenza, V.; Danza, F.M.; Lasorella, A. 1986: Possibility of using 131I-meta-iodobenzylguanidine in the diagnosis of neuroendocrine tumors differing from pheochromocytomas La Radiologia Medica 72(12): 963-968
Raes, M.; Coolens, J.L.; Van de Casseye, W.; Casteels-Van Daele, M.; De Roo, M. 1986: The use of 131I-meta-iodobenzylguanidine in clinical diagnosis and staging of neuroectodermal tumors. Two case reports Helvetica Paediatrica Acta 41(1-2): 63-67
Maurelli, L.; Cuocolo, A.; Lastoria, S.; Brunetti, A.; Maurea, S.; Lembo, G.; Klain, M.; Caracò, C.; Salvatore, M. 1991: 131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. a comparison with CT and biohumoral parameters La Radiologia Medica 82(6): 839-843
Kolesnik, V.S.; Kolesnik, R.S.; Sorkin, I.I.; Kalinovskiĭ, A.I.; Tafel'shteĭn, E.E.; Starovoĭtova, T.P. 1990: Experimental anthrax infection in laboratory animals with differing species susceptibility to the causative agent Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 3-7
Momo, K.; Someya, K.; Tachiiri, T.; Mitsuoka, Y.; Nakamura, K.; Imai, S.; Ino, T.; Ohkubo, H. 1992: Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals Arzneimittel-Forschung 42(1): 32-39
Acar, P.; Merlet, P.; Iserin, L.; Bonnet, D.; Aggoun, Y.; Sidi, D.; Kachaner, J. 1996: Cardiac MIBG imaging: a new marker for myocardial function in children? Archives des Maladies du Coeur et des Vaisseaux 89(5): 599-604
Martins, E.; Faria, T.; Silva-Cardoso, J.; Oliveira, A.; Campelo, M.; Amorim, S.; Moura, B.; Rocha-Gonçalves, F.; Pereira, J.G.; Maciel, M.J.úl. 2009: I-123-MIBG cardiac uptake imaging, in familial dilated cardiomyopathy Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 28(1): 29-36
Hasegawa, T.; Retief, D.H. 1994: Laboratory evaluation of experimental restorative systems containing 4-META American Journal of Dentistry 7(4): 212-216
Sheu, R.S.; Liu, G.C.; Wang, Y.M.; Jaw, T.S.; Chen, H.M.; Kuo, Y.T. 1997: Preclinical evaluation of Fe-(5-C2H5-EHPG)- as a contrast agent in MR imaging of hepatobiliary system Kaohsiung Journal of Medical Sciences 13(2): 75-85